TrialInvestigational new drugs2021

First-in-human, phase I/IIa study of CRLX301, a nanoparticle drug conjugate containing docetaxel, in patients with advanced or metastatic solid malignancies.

Sarina A Piha-Paul et al.PubMed ↗Publisher ↗

No numbers read from the abstract.